A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers

著录项

• 来源
  《Clinical chemistry and laboratory medicine: CCLM》 |2020年第3期|共9页
• 作者

  PaulaLafuente-Ganuza; PalomaLequerica-Fernandez; FranciscoCarretero; Ana I.Escudero; EduardoMartinez-Morillo; EnricSabria; IgnacioHerraiz; AlbertoGalindo; AnaLopez; Maria L.Martinez-Triguero; Francisco V.Alvarez;

  展开▼
• 作者单位

  Clinical Biochemistry Laboratory Medicine Hospital Universitario Central de Asturias Avenida de;

  Clinical Biochemistry Laboratory Medicine Hospital Universitario Central de Asturias Avenida de;

  Catedra de Inteligencia Analítica Universidad de Oviedo Oviedo Spain;

  Obstetrics and Gynaecology Department Hospital Universitario Central de Asturias Oviedo Spain;

  Clinical Biochemistry Laboratory Medicine Hospital Universitario Central de Asturias Avenida de;

  Obstetrics and Gynaecology Department Hospital-Residencia Sant Camil Barcelona Spain;

  Fetal Medicine Unit Maternal and Child Health and Development Network Department of Obstetrics;

  Fetal Medicine Unit Maternal and Child Health and Development Network Department of Obstetrics;

  Clinical Laboratory University Hospital 12 de Octubre Madrid Spain;

  Clinical Laboratory Hospital La Fe Valencia Spain;

  Clinical Biochemistry Laboratory Medicine Hospital Universitario Central de Asturias Avenida de;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 诊断学;
• 关键词

  NT-proBNP; placental growth factor (PlGF); pre-eclampsia; soluble FMS-like tyrosine kinase 1 (sFlt-1);

  机译：nt-probnp;胎盘生长因子（PLGF）;预兴普氏症;可溶性FMS样酪氨酸激酶1（SFLT-1）;